Incidence of Micromelia
The provided evidence does not contain specific population-based incidence data for micromelia as an isolated finding. Micromelia is not a standalone diagnosis but rather a sonographic finding that serves as a key indicator of underlying skeletal dysplasias, which collectively occur in approximately 1 in 100,000-130,000 live births 1.
What the Evidence Actually Addresses
The guidelines focus on micromelia as a diagnostic criterion and predictor of lethality in skeletal dysplasias rather than providing incidence rates 2:
Micromelia as a Clinical Finding
- Micromelia 3 SD below the mean is identified as one of the key predictors of lethality at 18-20 weeks gestation ultrasound 2
- It is part of a constellation of findings used to assess skeletal dysplasias, not tracked as an independent epidemiologic entity
- The finding warrants further evaluation when femur length falls below the 5th percentile for gestational age during 18-22 week ultrasound 2
Detection Timing
- Most severe skeletal dysplasias (which present with micromelia) are detected at routine 18-20 week ultrasound 2
- Nonlethal skeletal dysplasias may not be evident until 28 weeks gestation or even birth 2
- Increased nuchal translucency at 10-14 weeks can be an early sign of severe skeletal dysplasia 2
Context from Specific Conditions
The only concrete incidence data provided relates to Jeune syndrome (asphyxiating thoracic dysplasia), which presents with micromelia and has a reported incidence of 1 in 100,000-130,000 live births 1. This represents just one of many skeletal dysplasias that manifest with micromelia.
Important Clinical Caveat
Micromelia is a sonographic measurement finding, not a disease entity. When detected, it requires systematic evaluation including:
- Chest-to-abdomen ratio assessment
- Femur length-to-abdominal circumference ratio (FL/AC <0.16 strongly predicts lethality) 2
- Assessment for hydrops, decreased mineralization, and thoracic hypoplasia 2
- Referral to high-risk maternal-fetal medicine specialists for comprehensive evaluation 2
The absence of population-based incidence data for micromelia itself reflects that it functions as a diagnostic marker rather than a diagnosis, requiring further workup to identify the specific underlying skeletal dysplasia.